Fink H - Search Results

1

Sugammadex as a reversal agent for neuromuscular block: an evidence-based review.

Schaller SJ, Fink H. Schaller SJ, et al. Among authors: fink h. Core Evid. 2013;8:57-67. doi: 10.2147/CE.S35675. Epub 2013 Sep 25. Core Evid. 2013. PMID: 24098155 Free PMC article. Review.

2

Sugammadex and neostigmine dose-finding study for reversal of shallow residual neuromuscular block.

Schaller SJ, Fink H, Ulm K, Blobner M. Schaller SJ, et al. Among authors: fink h. Anesthesiology. 2010 Nov;113(5):1054-60. doi: 10.1097/ALN.0b013e3181f4182a. Anesthesiology. 2010. PMID: 20885293 Free article. Clinical Trial.

3

Neuromuscular blockade improves surgical conditions (NISCO).

Blobner M, Frick CG, Stäuble RB, Feussner H, Schaller SJ, Unterbuchner C, Lingg C, Geisler M, Fink H. Blobner M, et al. Among authors: fink h. Surg Endosc. 2015 Mar;29(3):627-36. doi: 10.1007/s00464-014-3711-7. Epub 2014 Aug 15. Surg Endosc. 2015. PMID: 25125097 Clinical Trial.

4

Postoperative impairment of motor function at train-of-four ratio ≥0.9 cannot be improved by sugammadex (1 mg kg-1).

Baumüller E, Schaller SJ, Chiquito Lama Y, Frick CG, Bauhofer T, Eikermann M, Fink H, Blobner M. Baumüller E, et al. Among authors: fink h. Br J Anaesth. 2015 May;114(5):785-93. doi: 10.1093/bja/aeu453. Epub 2015 Jan 13. Br J Anaesth. 2015. PMID: 25586724 Free article. Clinical Trial.

5

Sugammadex and neostigmine dose-finding study for reversal of residual neuromuscular block at a train-of-four ratio of 0.2 (SUNDRO20)†,

Kaufhold N, Schaller SJ, Stäuble CG, Baumüller E, Ulm K, Blobner M, Fink H. Kaufhold N, et al. Among authors: fink h. Br J Anaesth. 2016 Feb;116(2):233-40. doi: 10.1093/bja/aev437. Br J Anaesth. 2016. PMID: 26787792 Free article. Clinical Trial.

6

Effects of single-shot and steady-state propofol anaesthesia on rocuronium dose-response relationship: a randomised trial.

Stäuble CG, Stäuble RB, Schaller SJ, Unterbuchner C, Fink H, Blobner M. Stäuble CG, et al. Among authors: fink h. Acta Anaesthesiol Scand. 2015 Aug;59(7):902-11. doi: 10.1111/aas.12523. Epub 2015 May 12. Acta Anaesthesiol Scand. 2015. PMID: 25962311 Clinical Trial.

7

The use of sugammadex in a patient with myasthenia gravis.

Unterbuchner C, Fink H, Blobner M. Unterbuchner C, et al. Among authors: fink h. Anaesthesia. 2010 Mar;65(3):302-5. doi: 10.1111/j.1365-2044.2009.06236.x. Epub 2010 Jan 23. Anaesthesia. 2010. PMID: 20105151 Free article.

8

Myths and facts in neuromuscular pharmacology. New developments in reversing neuromuscular blockade.

Fink H, Hollmann MW. Fink H, et al. Minerva Anestesiol. 2012 Apr;78(4):473-82. Minerva Anestesiol. 2012. PMID: 22454044 Free article. Review.

9

Development of an algorithm using clinical tests to avoid post-operative residual neuromuscular block.

Unterbuchner C, Blobner M, Pühringer F, Janda M, Bischoff S, Bein B, Schmidt A, Ulm K, Pithamitsis V, Fink H. Unterbuchner C, et al. Among authors: fink h. BMC Anesthesiol. 2017 Aug 4;17(1):101. doi: 10.1186/s12871-017-0393-4. BMC Anesthesiol. 2017. PMID: 28778151 Free PMC article. Clinical Trial.

10

Continuous administration of pyridostigmine improves immobilization-induced neuromuscular weakness.

Frick CG, Helming M, Martyn JA, Blobner M, Fink H. Frick CG, et al. Among authors: fink h. Crit Care Med. 2010 Mar;38(3):922-7. doi: 10.1097/CCM.0b013e3181c31297. Crit Care Med. 2010. PMID: 20009758

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

627 results

Search Page